Seth Harrison, M.D.

Seth Harrison is chairman of the board of directors at Stoke Therapeutics, as well as the founder and managing partner of Apple Tree Partners (ATP). He has invested in life sciences since 1991. Seth is also currently chairman of ATP companies Braeburn Pharmaceuticals, Elstar Therapeutics and Limelight Bio, and is a director of Corvidia Therapeutics. His prior investments include Aileron Therapeutics, ArQule, Coelacanth, Cyrano Sciences, Gloucester Pharmaceuticals, HeartWare International, Informed Access, SGX Pharmaceuticals, Tokai Pharmaceuticals, Ultracision and ViroPharma. From 2002 to 2010, Seth served on the board of the International Partnership for Microbicides. Prior to founding ATP in 1999, Seth was a general partner at Oak Investment Partners, and before that a venture partner at Sevin Rosen Funds. Seth received his A.B. from Princeton University and an M.D. and MBA from Columbia University. He completed a surgery internship at the Presbyterian Hospital in the City of New York.